Catalent Pharma Solutions celebrates the 50th anniversary of its Schorndorf, Germany facility, which specializes in modified release technologies and clinical supply services.

The Schorndorf facility first opened in 1961 as Allpack and grew to serve the pharmaceutical industry in service areas such as clinical supply, manufacturing, quality assurance and R&D. In recent years, the facility doubled GMP production capacity, built a new distribution center for clinical trial medication, and doubled its lab space.

“We are extremely proud of Schorndorf’s rich 50-year history and proven excellence in providing a full-range of services and innovative solutions to meet the increasingly complex needs of our customers,” said Ian Muir, Ph.D., president, Modified Release Technologies, Catalent Pharma Solutions. “Our focus on reliability combined with our diverse employee base, and long-term customer partnerships, have made us successful in broadening Schorndorf’s roots and optimizing our offerings.”

The Schorndorf facility has been supporting global pharmaceutical companies such as Lilly. “Over the years Lilly has established an enduring partnership with Catalent Germany Schorndorf GmbH,” said Sherman Whitfield, director, Office of Alliance Management, Lilly.


Click here to learn more about Catalent